Atlas Trials

Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT01093911 · COMPLETED

Trial details

NCT number
NCT01093911
Sponsor
UCB Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Immune System DiseasesAutoimmune DiseasesLupus Erythematosus, SystemicSkin and Connective Tissue DiseasesConnective Tissue Disease
Start date
2010-03-01
Primary completion
2012-12-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.